Morfin Alternova (Morphine Hydrochloride)

Morphine, the active ingredient in Morfin Alternova, is an opioid analgesic presented as an oral formulation for oral use. It treats moderate to severe acute pain, post‑operative pain and cancer‑related pain in adult patients.

GNH USA supplies Morfin Alternova as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine acts on the opioid pathway to provide analgesia in several pain conditions.

- Moderate to severe acute pain: provides rapid pain relief in acute injury or illness. - Post‑operative pain: reduces pain after surgical procedures. - Cancer‑related pain: manages persistent pain associated with malignancy.

Morphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: mild to moderate upset stomach. - Drowsiness: increased sedation. - Dry mouth: reduced salivation. - Sweating: excessive perspiration. - Itching: mild pruritus.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, potentially life‑threatening. - Hypotension: marked drop in blood pressure. - Severe allergic reaction: rash, swelling, anaphylaxis. - Dependence or addiction: risk of misuse with prolonged use. - Withdrawal syndrome: symptoms on abrupt discontinuation. - Opioid‑induced hyperalgesia: increased sensitivity to pain.

When prescribing or dispensing Morphine, careful assessment and monitoring are essential.

- Assess pain severity: confirm that pain is moderate to severe before initiating therapy. - Evaluate respiratory function: monitor for signs of depression, especially in opioid‑naïve patients. - Review medical history: consider comorbidities such as renal or hepatic impairment. - Counsel on constipation: advise prophylactic laxatives and hydration. - Avoid use in children: not indicated for pediatric pain management. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Morphine interacts with several drug classes that can alter its safety or efficacy.

Major Interactions (Avoid): - Benzodiazepines: combined CNS depression can cause profound respiratory depression. - MAO inhibitors: risk of severe hypotension and serotonin syndrome. - CNS depressants (e.g., barbiturates, alcohol): may potentiate sedation and respiratory effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may increase morphine plasma levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect. - Anticholinergics: can exacerbate constipation. - Diuretics: may enhance orthostatic hypotension. - Antidepressants (SSRIs, SNRIs): monitor for serotonin syndrome when combined with MAO inhibitors.